| NSAID | Nonsteroidal anti-inflammatory drug |
| TME | Tumor microenvironment |
| CP | Cisplatin |
| Npx | Naproxenate |
| SBA-15 | Santa Barbara Amorphous-15, nanostructured silica |
| i.e., | Id est, in other words |
| DNA | Deoxyribonucleic acid |
| e.g., | For example |
| COX-1 | Cyclooxygenase 1 |
| COX-2 | Cyclooxygenase 2 |
| PGE2 | Prostaglandin E2 |
| MSN | Nanostructured silica materials |
| EPR effect | Enhanced permeability and retention effect |
| Oxa | Oxaliplatin |
| [CP(Npx)2] | Platinum(IV)-naproxenate conjugate |
| DMSO | Dimethyl sulfoxide |
| PBS | Phosphate-buffered saline |
| AO | Acridine orange |
| PI | Propidium iodide |
| CFSE | Carboxyfluorescein diacetate succinimidyl ester |
| RNase | Ribonuclease A |
| TRIS HCL | Trisaminomethane hydrochloride |
| 3-MA | 3-methyl adenine |
| DTT | Dithiothreitol |
| L-DOPA | 3,4-dihydroxy-L-phenylalanine |
| CV | Crystal violet |
| FBS | Fetal bovine serum |
| RPMI | Roswell Park Memorial Institute, cell culture medium |
| DMEM | Dulbecco’s Modified Eagle Medium |
| EDTA | Ethylenediaminetetraacetic acid |
| PFA | Paraformaldehyde |
| TEMED | N,N,N′,N′-tetramethylethylenediamine |
| FDG | Fluorescein di-β-D-galactopyranoside |
| AnnV | Annexin V-FITC |
| DHR | Dihydrorhodamine 123 |
| DAF-FM | 4-amino-5-methylamino-2′,7′-difluorofluorescein |
| NaOH | Sodium hydroxide |
| MTT | 3-(4,5-Dimethythiazol-2-yl)-2,5-diphenyltetrazolium bromide |
| BSA | Bovine serum albumin |
| SDS | Sodium dodecyl sulfate |
| ECL | Electrochemiluminescence |
| PVDF | Polyvinylidene difluoride |
| B16 | Mouse melanoma cell line |
| CT26 | Mouse colorectal carcinoma cell line |
| MC38 | Mouse colon adenocarcinoma cell line |
| 4T1 | Mouse mammary carcinoma cell line |
| NIH/3T3 | Mouse fibroblast cell line |
| CO2 | Carbon dioxide |
| C57BL/6 | Black laboratory mouse |
| IACUC | Institutional Animal Care and Use Committee |
| i.p. | Intraperitoneal injection |
| NBF | Neutral buffered formalin |
| SI | Selectivity index |